Chronic Myeloid Leukaemia (CML)
More than 100 clinical trials are currently accepting participants diagnosed with Chronic Myeloid Leukemia (CML).
Chronic Myeloid Leukemia (CML) specifically arises from early blood cells known as myeloid blood stem cells. This type of leukemia is characterized by its slow progression. Like other leukemias, CML requires treatment approaches tailored to its specific type and characteristics.